“…Antibiotic sensitivity profile of bacteria isolated from bronchoalveolar lavage culture using bronchoscopy fiber flexural optics and from endotracheal aspirate culture using catheter hose.PAGE 44Indonesian Journal of Clinical Pathology and Medical Laboratory, 2019 Nov, 26(1) :40 -45 Empirical antibiotic therapy for early-onset V A P i s b e t a -l a c t a m / a n t i -b e t a -l a c t a m a s e (amoxicillin-clavulanate), third-generation antipseudomonal cephalosporins (ceftriaxone, cefotaxime) or quinolone (levofloxacin). Whereas empirical antibiotic therapy for late-onset VAP is antipseudomonal cephalosporin (cefepime, ceftazidime), antipseudomonal carbapenem (meropenem, imipenem) or beta-lactam/anti b e t a -l a c t a m a s e ( p i p e r a c i l l i n -t a z o b a c t a m ) , s u p p l e m e n t i o n w i t h a n t i p s e u d o m o n a l fluoroquinolone (ciprofloxacine or levofloxacine) or aminoglycosides (amikacine, gentamicine or tobramicine), supplemention with Linezolide or 9 vancomicine (if suspected of MRSA).…”